LCTX Change in Working Capital

Lineage Cell Therapeutics, Inc. Common Stock · Change in Working Capital

LCTX logo

LCTX Change in Working Capital

Latest reported-$3.97M
LCTX TTM Change in Working Capital ($200.00K → -$3.97M)
High-resolution chart · PNG

LCTX change in working capital history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Change in Working Capital — Trailing twelve months (TTM) (USD)
Period endingChange in Working Capital (USD)
-3,974,000
-5,960,000
-4,110,000
-7,210,000
-9,349,000
-8,105,000
-8,766,000
-6,976,000
-3,398,000
-5,311,000
-10,718,000
-12,322,000
-13,116,000
-14,756,000
18,704,000
42,821,000
44,405,000
49,568,000
21,110,000
-869,000
-553,000
-803,000
1,128,000
1,150,000
-895,000
-2,203,000
-1,956,000
-14,000
1,779,000
2,351,000
638,000
900,000
-452,000
137,000
2,478,000
1,654,000
63,000
-543,000
-741,000
30,000
3,121,000
4,948,034
3,305,000
2,933,107
2,879,547
521,281
-827,050
-515,328
710,364
1,069,409
2,725,802
2,173,582
-229,744
1,375,668
468,013
320,850
-161,309
-135,490
26,122
-1,107,068
-348,811
-1,180,279
-447,763
153,240
-509,080
-359,935
-306,100
528,362
1,635,385
1,329,022
1,442,426
540,421
176,470
126,104
106,959
37,419
85,578
674,438
269,435
1,021,205
664,162
113,473
485,573
-21,318
548,961
593,157
353,543
-97,314
-430,560
-69,724
126,002
341,500
300,419
199,053
74,336
120,311
75,447
33,510
-38,534
15,554
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.